Receptor-mediated folate accumulation is regulated by the cellular folate content
about
Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositolDelivery of macromolecules into living cells: a method that exploits folate receptor endocytosisMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Polymer-coated echogenic lipid nanoparticles with dual release triggers.The rate of folate receptor alpha (FR alpha) synthesis in folate depleted CHL cells is regulated by a translational mechanism sensitive to media folate levels, while stable overexpression of its mRNA is mediated by gene amplification and an increaseAvidity mechanism of dendrimer-folic acid conjugates.Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate.Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticlesEnzymatic synthesis and in vitro evaluation of folate-functionalized liposomesBlast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.Megaloblastic hematopoiesis in vitro. Interaction of anti-folate receptor antibodies with hematopoietic progenitor cells leads to a proliferative response independent of megaloblastic changes.Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake.Synthesis of folate-functionalized RAFT polymers for targeted siRNA delivery.Identification of high affinity folate binding proteins in human erythrocyte membranes.Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cellsDesign and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acidsDendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug delivery.Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.The effect of folate on the methotrexate/indomethacin interaction in a murine cancer cell line.Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway.Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae.Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation.Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells.Hormonal regulation of caveolae internalization.Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas.Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folateImproved biochemical strategies for targeted delivery of taxoidsSynthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy.Biomarkers of folate and vitamin B(12) status in cerebrospinal fluid.Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticlesTissue distribution and tumor uptake of folate receptor-targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration.18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging.
P2860
Q24304949-DCBA7511-53D8-4498-B2D5-1B66A0B3D2D1Q24564481-68779136-27EF-4BAB-8BC5-1B267F07BA41Q26852723-B327B8AC-47AC-4EA4-B1F3-82C03C152195Q28068437-22F5ED3E-8F69-42EE-A0B0-5341BF819274Q30366990-83FB5627-018C-443B-A4FE-7A33133149BCQ30441883-83556FCF-1328-42F2-9EB3-3466F53B9F7AQ30657701-9C72A447-4D9F-4882-AF9F-9EFA4830DF11Q33598717-9B47D238-690F-4AEE-8858-4F3D40FD2D92Q33612375-02BC719A-89F9-4081-9B01-085F5B39205FQ33755231-FAF864C6-A3BC-44A6-A9B7-FAAB07242F53Q33834802-F9EFF83D-8382-4ABB-BE49-D9B19A47BBA6Q34157974-06845E58-8DB7-49F9-B20A-C0C68976A90BQ34178043-E93C9687-7DAE-4956-8768-2EA4E2D939D2Q34382612-E9A7C347-0AAC-43EE-8B3A-4069212A7BC6Q35138592-EA6F2CB5-68A7-46A1-AF19-53F39A8A80AFQ35578554-458CEE65-6AED-4178-A948-5BBDE2C47D6BQ35587783-5B53580C-7E22-4F61-9E38-FE01C6D19121Q35613117-18CE16E3-43DF-4171-A276-26AC71902897Q35624762-A049D014-4E4F-4330-B534-EFCDBF3C8551Q35672613-76D74E8E-EA1A-44A7-B127-B589827EA601Q35688131-3AD8FCAE-6E55-4B5D-B106-6079CA61A83DQ35780797-BF79F653-0739-4717-B041-8D30FB8CE13BQ35832275-ECABA4CA-C448-4EC8-82D9-398F930CF855Q35872985-87605419-312E-4C30-A78F-5A9C70D11C67Q35915267-FC69A182-95AF-446F-8265-5D8A3BDD8165Q36222686-E22B9BE9-6951-40ED-8E99-1CBDAA74988AQ36233754-C5B2A19E-84E3-495E-A7FD-40E2957C1718Q36234912-4697495D-FC82-42FF-B220-656A013BFF6BQ36237309-9950FBA2-2879-4A5A-B705-AEAB34C949C2Q36382786-BEDA9BB4-3048-4128-ADFA-383EB981DAF8Q36420244-99016F06-FC99-4ED2-9D68-7AFC884BD4B8Q36422416-9FBBB127-5882-4B0D-AD3B-BE434E124C6CQ36492327-49D0A830-2371-4DD0-859B-8D9F4B726FF0Q36531594-0F9084AD-49CF-40BF-8F7D-D1DB964FAB44Q36642502-047560C5-FFA7-4B3C-9246-28CBB31CB9C9Q36781046-C96D48EB-A195-4374-9DE8-0DEB3F6B4147Q36950520-37B04ACF-E4D4-493B-A162-598A43093469Q37198647-126961AA-7A46-423B-83EC-4439AACA5206Q37302203-B85692BA-D6ED-4C87-8C39-DA271CD457B0Q37360664-0F3820A3-228E-4E81-A1CE-662532DD3A9E
P2860
Receptor-mediated folate accumulation is regulated by the cellular folate content
description
1986 nî lūn-bûn
@nan
1986 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Receptor-mediated folate accumulation is regulated by the cellular folate content
@ast
Receptor-mediated folate accumulation is regulated by the cellular folate content
@en
Receptor-mediated folate accumulation is regulated by the cellular folate content
@nl
type
label
Receptor-mediated folate accumulation is regulated by the cellular folate content
@ast
Receptor-mediated folate accumulation is regulated by the cellular folate content
@en
Receptor-mediated folate accumulation is regulated by the cellular folate content
@nl
prefLabel
Receptor-mediated folate accumulation is regulated by the cellular folate content
@ast
Receptor-mediated folate accumulation is regulated by the cellular folate content
@en
Receptor-mediated folate accumulation is regulated by the cellular folate content
@nl
P2860
P3181
P356
P1476
Receptor-mediated folate accumulation is regulated by the cellular folate content
@en
P2093
A Capdevila
P2860
P304
P3181
P356
10.1073/PNAS.83.16.5983
P407
P577
1986-08-01T00:00:00Z